208 related articles for article (PubMed ID: 22653543)
1. Role of hyperglycemia-mediated erythrocyte redox state alteration in the development of diabetic retinopathy.
Choudhuri S; Mandal LK; Paine SK; Sen A; Dutta D; Chowdhury IH; Mukherjee A; Saha A; Bhadhuri G; Bhattacharya B
Retina; 2013 Jan; 33(1):207-16. PubMed ID: 22653543
[TBL] [Abstract][Full Text] [Related]
2. Role of hyperglycemia-mediated erythrocyte redox state alteration in the development of diabetic retinopathy.
Roy R; Das D; Saurabh K; Kulkarni VV; Adusumilli H; Panigrahi PK; Nethralaya AB
Retina; 2013; 33(7):1480-1. PubMed ID: 23967450
[No Abstract] [Full Text] [Related]
3. Hyperlipidemia-Mediated Increased Advanced Lipoxidation End Products Formation, an Important Factor Associated with Decreased Erythrocyte Glucose-6-Phosphate Dehydrogenase Activity in Mild Nonproliferative Diabetic Retinopathy.
Choudhuri S; Roy PK; Mitra B; Sen S; Sarkar R; Das M; Biswas D; Ghosh P; Biswas A; Chakraborty S; Mondal LK
Can J Diabetes; 2017 Feb; 41(1):82-89. PubMed ID: 27916496
[TBL] [Abstract][Full Text] [Related]
4. Association of hyperglycemia mediated increased advanced glycation and erythrocyte antioxidant enzyme activity in different stages of diabetic retinopathy.
Choudhuri S; Dutta D; Chowdhury IH; Mitra B; Sen A; Mandal LK; Mukhopadhyay S; Bhattacharya B
Diabetes Res Clin Pract; 2013 Jun; 100(3):376-84. PubMed ID: 23602454
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell membrane mechanical fluctuations in non-proliferative and proliferate diabetic retinopathy.
Goldstein M; Leibovitch I; Levin S; Alster Y; Loewenstein A; Malkin G; Korenstein R
Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):937-43. PubMed ID: 15293056
[TBL] [Abstract][Full Text] [Related]
6. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
7. Serum erythropoietin concentration and its correlation with stage of diabetic retinopathy.
Davidović S; Babić N; Jovanović S; Barišić S; Grković D; Miljković A
BMC Ophthalmol; 2019 Nov; 19(1):227. PubMed ID: 31727007
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy.
Lopes de Faria JM; Silveira LA; Morgano M; Pavin EJ; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1482-5. PubMed ID: 10798666
[TBL] [Abstract][Full Text] [Related]
9. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
10. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.
Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S
Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732
[TBL] [Abstract][Full Text] [Related]
11. Levels of Interleukin 27 and Interleukin 35 in the Serum and Vitreous of Patients with Proliferative Diabetic Retinopathy.
Yan A; You H; Zhang X
Ocul Immunol Inflamm; 2018; 26(2):273-279. PubMed ID: 27537610
[TBL] [Abstract][Full Text] [Related]
12. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
[TBL] [Abstract][Full Text] [Related]
13. Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors.
Lu W; Wang L; Chen L; Hui S; Rabinowitz JD
Antioxid Redox Signal; 2018 Jan; 28(3):167-179. PubMed ID: 28497978
[TBL] [Abstract][Full Text] [Related]
14. Reply: To PMID 22653543.
Choudhuri S; Mandal LK; Paine SK; Sen A; Dutta D; Chowdhury IH; Mukherjee A; Saha A; Bhadhuri G; Bhattacharya B
Retina; 2013; 33(7):1481. PubMed ID: 23656905
[No Abstract] [Full Text] [Related]
15. Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease.
Zerez CR; Lachant NA; Lee SJ; Tanaka KR
Blood; 1988 Feb; 71(2):512-5. PubMed ID: 3337912
[TBL] [Abstract][Full Text] [Related]
16. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
Obrosova IG; Stevens MJ
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
[TBL] [Abstract][Full Text] [Related]
17. Serum and tear levels of nerve growth factor in diabetic retinopathy patients.
Park KS; Kim SS; Kim JC; Kim HC; Im YS; Ahn CW; Lee HK
Am J Ophthalmol; 2008 Mar; 145(3):432-7. PubMed ID: 18282491
[TBL] [Abstract][Full Text] [Related]
18. Vascular responsiveness in type 2 diabetes mellitus (T2DM).
Blum A; Socea D; Sirchan R
QJM; 2016 Dec; 109(12):791-796. PubMed ID: 27289111
[TBL] [Abstract][Full Text] [Related]
19. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device.
Zeng Y; Cao D; Yang D; Zhuang X; Yu H; Hu Y; Zhang Y; Yang C; He M; Zhang L
Doc Ophthalmol; 2020 Jun; 140(3):211-220. PubMed ID: 31720980
[TBL] [Abstract][Full Text] [Related]
20. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.
Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU
Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
